Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-23

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental ANDA for oxymorphone hydrochloride from Epic Pharma, LLC, authorizing a generic oxymorphone hydrochloride product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)